Clinical study of Endostar plus capecitabine combined with stereotactic radiotherapy in the treatment of advanced pancreatic cancer subjects open, single group phase II
Phase of Trial: Phase II
Latest Information Update: 04 May 2016
Price : $35 *
At a glance
- Drugs Endostatin (Primary) ; Capecitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 02 May 2016 Status changed from recruiting to completed, as reported by Chinese Clinical Trial Registry.
- 02 Jun 2015 Interim results in 13 patients presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 30 Oct 2013 New trial record